Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension, May 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 112 articles:
HTML format


 

Single Articles

  1. WANG J, Lei K, Li J, Zhang Y, et al
    Analysis of clinical features and prognostic factors in Takayasu arteritis involving pulmonary hypertension: A retrospective study.
    Medicine (Baltimore). 2024;103:e37992.
    PubMed    
    Abstract available

  2. NIKITIN D, Lin GA, Whittington MD, Nhan E, et al
    The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.
    J Manag Care Spec Pharm. 2024;30:491-495.
    PubMed    


  3. TOROK RD, Gardner RA, Barker PCA, McCrary AW, et al
    Correlating Severity of Pulmonary Hypertension by Echocardiogram with Mortality in Premature Infants with Bronchopulmonary Dysplasia.
    Am J Perinatol. 2024 May 2. doi: 10.1055/s-0044-1786544.
    PubMed    
    Abstract available

  4. LIU W, Xu Y, Yang L, Zhan S, et al
    Risk factors associated with pulmonary hypertension in patients with active tuberculosis and tuberculous destroyed lung: a retrospective study.
    Sci Rep. 2024;14:10108.
    PubMed    
    Abstract available


  5. Sotatercept (Winrevair) for pulmonary arterial hypertension.
    Med Lett Drugs Ther. 2024;66:73-75.
    PubMed    


  6. CAZEIRO DI, Placido R, Raposo MA, Brito J, et al
    Pulmonary Arterial Hypertension with Features of Venous Involvement: A Detective's Task.
    Arq Bras Cardiol. 2024;121:e20230565.
    PubMed    
    Abstract available

  7. BJORK S, Jain D, Marliere MH, Predescu SA, et al
    Obstructive Sleep Apnea, Obesity Hypoventilation Syndrome, and Pulmonary Hypertension: A State-of-the-Art Review.
    Sleep Med Clin. 2024;19:307-325.
    PubMed    
    Abstract available

  8. LI H, Li J, Huang J, Jiang D, et al
    A review regarding the article 'Effectiveness of Mechanical Circulatory Support Devices in Reversing Pulmonary Hypertension Among Heart Transplant Candidates: A Systematic Review.'.
    Curr Probl Cardiol. 2024 Apr 29:102614. doi: 10.1016/j.cpcardiol.2024.102614.
    PubMed    
    Abstract available

  9. YOKOKAWA T, Nishiura K, Katahira M, Sato Y, et al
    Collagen triple helix repeat-containing protein 1 is a novel biomarker of right ventricular involvement in pulmonary hypertension.
    Can J Cardiol. 2024 Apr 29:S0828-282X(24)00337.
    PubMed    
    Abstract available

  10. FISH A, Wang D, Knight E, Pollak J, et al
    Recurrence of Pulmonary Arteriovenous Malformation after Embolization in Patients with Pulmonary Hypertension.
    J Vasc Interv Radiol. 2024 Apr 29:S1051-0443(24)00322.
    PubMed    
    Abstract available

  11. SATO M, Saiki H, Saito K, Sato A, et al
    Successful Atrial Septal Defect Closure Subsequent to Medical Pulmonary Preconditioning in an Infant With Severe Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia.
    Cureus. 2024;16:e57290.
    PubMed    
    Abstract available

  12. ENENCHE AA, Kweki AG, Aiwuyo HO, Akinti OM, et al
    Prevalence of Pulmonary Hypertension in Liver Cirrhosis Patients: A Cross-Sectional Analytical Study.
    Cureus. 2024;16:e57313.
    PubMed    
    Abstract available

  13. KUMAR S, Mickael C, Kumar R, Prasad RR, et al
    Single cell transcriptomic analyses reveal diverse and dynamic changes of distinct populations of lung interstitial macrophages in hypoxia-induced pulmonary hypertension.
    Front Immunol. 2024;15:1372959.
    PubMed    
    Abstract available

  14. DALLAPE DE LA RETA N, Oscos M, Pedroni P, Giachello F, et al
    Extrinsic compression of left main coronary artery due to pulmonary artery aneurysm and pulmonary hypertension.
    Radiol Case Rep. 2024;19:2837-2840.
    PubMed    
    Abstract available

  15. KREMER N, Glocker F, Schafer S, Rako Z, et al
    Precision cardiac monitoring: algorithmic real-time assessment of right ventricular function in pulmonary hypertension.
    ESC Heart Fail. 2024 Apr 30. doi: 10.1002/ehf2.14833.
    PubMed    


  16. LAMMI MR, Mukherjee M, Saketkoo LA, Carey K, et al
    Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trial.
    BMC Pulm Med. 2024;24:211.
    PubMed    
    Abstract available

  17. MORALES-DEMORI R, Coleman R, Mallory GB
    Pediatric Pulmonary Hypertension.
    Pediatr Rev. 2024;45:251-259.
    PubMed    


  18. JANG D, Darling R, Choudhary G, Jankowich M, et al
    Hemorrhagic Adverse Events of Transthoracic Needle Biopsy of the Lung in Patients with Pulmonary Hypertension: A Systematic Review and Meta-AnalysisPercutaneous.
    J Vasc Interv Radiol. 2024 Apr 27:S1051-0443(24)00319.
    PubMed    
    Abstract available

  19. SATO T, Fukui S, Nakano T, Hasegawa K, et al
    Balloon pulmonary angioplasty under awake veno-arterial extracorporeal membrane oxygenation in a patient with class III obesity with chronic thromboembolic pulmonary hypertension complicated with multiple serious comorbidities.
    Pulm Circ. 2024;14:e12377.
    PubMed    
    Abstract available

  20. KE DYJ, Tso M, Johri AM
    The Application of Point of Care Ultrasound to Screen for Pulmonary Hypertension: A Narrative Review.
    POCUS J. 2024;9:109-116.
    PubMed    
    Abstract available

  21. MILARA J, Roger I, Montero P, Artigues E, et al
    Targeting IL-11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension-associated lung fibrosis.
    Br J Pharmacol. 2024 Apr 28. doi: 10.1111/bph.16393.
    PubMed    
    Abstract available

  22. ORBAEK ANDERSEN M, Carlsen J
    Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records: A trial design.
    Contemp Clin Trials. 2024;142:107548.
    PubMed    
    Abstract available

  23. HOBOHM L, Paschke LM, Farmakis IT, Barco S, et al
    Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: data from a practice-based longitudinal cohort.
    J Thromb Haemost. 2024 Apr 25:S1538-7836(24)00227.
    PubMed    
    Abstract available

  24. JOHNSON CA JR, Cortelli M Jr, Glomp G, Cagnolatti C, et al
    A Dynamic Sheep Model to Induce Pulmonary Hypertension and Right Ventricular Failure.
    Methods Mol Biol. 2024;2803:239-258.
    PubMed    
    Abstract available

  25. KATZ MG, Hadas Y, Shtraizent N, Ravvin S, et al
    Unilateral Lung Removal in Combination with Monocrotaline or SU5416 in Rodents: A Reliable Model to Mimic the Pathology of the Human Pulmonary Hypertension.
    Methods Mol Biol. 2024;2803:173-185.
    PubMed    
    Abstract available

  26. BIKOU O, Sassi Y
    The Sugen/Hypoxia Rat Model for Pulmonary Hypertension and Right Heart Failure.
    Methods Mol Biol. 2024;2803:163-172.
    PubMed    
    Abstract available

  27. ZHANG J, Wen Y, Yin Y, Zhang Y, et al
    Impression life with pulmonary hypertension: clinically relevant characteristics and quality of life among patients in Gansu, China.
    Ther Adv Respir Dis. 2024;18:17534666241246428.
    PubMed    
    Abstract available

  28. KRIGERE A, Kalejs VR, Kaulins R, Rudzitis A, et al
    The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia.
    Medicina (Kaunas). 2024;60:568.
    PubMed    
    Abstract available

  29. YE L, Liu R, Li Q, Zhou C, et al
    Dysregulated VEGF/VEGFR-2 Signaling and Plexogenic Lesions in the Embryonic Lungs of Chickens Predisposed to Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2024;25:4489.
    PubMed    
    Abstract available

  30. CARDOUAT G, Douard M, Bouchet C, Roubenne L, et al
    NGF increases Connexin-43 expression and function in pulmonary arterial smooth muscle cells to induce pulmonary artery hyperreactivity.
    Biomed Pharmacother. 2024;174:116552.
    PubMed    
    Abstract available

  31. STRICKLAND B, Stuart Harris N
    Adapting nitric oxide: A review of its foundation, uses in austere medical conditions, and emerging applications.
    Nitric Oxide. 2024;146:58-63.
    PubMed    
    Abstract available

  32. CHEN X, Yu X, Lian G, Tang H, et al
    Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Biomed Pharmacother. 2024;174:116505.
    PubMed    
    Abstract available

  33. CHEN YJ, Li HF, Zhao FR, Yu M, et al
    Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling.
    Int Immunopharmacol. 2024;132:111946.
    PubMed    
    Abstract available

  34. ZHANG JJ, Mao-Mao, Shao MM, Wang MC, et al
    Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review.
    Phytomedicine. 2024;128:155535.
    PubMed    
    Abstract available

  35. MEYER FJ, Opitz C
    Post-Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline.
    Hamostaseologie. 2024;44:128-134.
    PubMed    
    Abstract available

  36. LEI W, Chen MH, Huang ZF, Chen XY, et al
    Salidroside protects pulmonary artery endothelial cells against hypoxia-induced apoptosis via the AhR/NF-kappaB and Nrf2/HO-1 pathways.
    Phytomedicine. 2024;128:155376.
    PubMed    
    Abstract available

  37. VOS JL, Lemmers JMJ, El Messaoudi S, Snoeren M, et al
    Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
    Eur Heart J Cardiovasc Imaging. 2024;25:708-717.
    PubMed    
    Abstract available

  38. BABA S, Ogawa E, Akagi K, Matsuda K, et al
    Hemodynamic and Clinical Response to Liver Transplantation in Children and Young Adults POPH Patients.
    Pediatr Cardiol. 2024;45:1142-1150.
    PubMed    
    Abstract available

  39. ZHANG L, Gu X
    4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling.
    Aging (Albany NY). 2024;16.
    PubMed    
    Abstract available

  40. FREIDKIN L, Kramer MR, Rosengarten D, Izhakian S, et al
    The acute effect of inhaled nitric oxide on the exercise capacity of patients with advanced interstitial lung disease: a randomized controlled trial.
    BMC Pulm Med. 2024;24:226.
    PubMed    
    Abstract available

  41. SHREYAS R, Patteri A, Hayagrivas MB, Singla T, et al
    Fatal pulmonary arterial hypertension (PAH): A rare association of anti-MDA-5 positive juvenile dermatomyositis.
    Int J Rheum Dis. 2024;27:e15180.
    PubMed    


  42. WANG D, Huang S, Cao J, Feng Z, et al
    A comprehensive study on machine learning models combining with oversampling for bronchopulmonary dysplasia-associated pulmonary hypertension in very preterm infants.
    Respir Res. 2024;25:199.
    PubMed    
    Abstract available

  43. LI XC, Zhu XY, Wang YY, Tong SL, et al
    Canagliflozin alleviates pulmonary hypertension by activating PPARgamma and inhibiting its S225 phosphorylation.
    Acta Pharmacol Sin. 2024 May 8. doi: 10.1038/s41401-024-01286.
    PubMed    
    Abstract available

  44. ORBAEK ANDERSEN M, Diederichsen SZ, Svendsen JH, Carlsen J, et al
    Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension.
    Open Heart. 2024;11:e002710.
    PubMed    
    Abstract available

  45. SHUFIAN ISHTIAQ AHMED A, Blood AB, Zhang L
    Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development.
    Drug Discov Today. 2024 May 6:104015. doi: 10.1016/j.drudis.2024.104015.
    PubMed    
    Abstract available

  46. ZHANG Y, Wen J, Zeng M, Zhang L, et al
    A Nomogram Prediction Model for Persistent Pulmonary Hypertension of the Newborn in Neonates Hospitalized for the First Time After Birth.
    Pediatr Emerg Care. 2024 May 9. doi: 10.1097/PEC.0000000000003167.
    PubMed    
    Abstract available

  47. ACAR C, Sahin G, Yuksel HC, Karaca B, et al
    Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension.
    J Chemother. 2024 May 8:1-6. doi: 10.1080/1120009X.2024.2349858.
    PubMed    
    Abstract available

  48. ZHANG Q, Liu H, Liu C, Wang Y, et al
    Tibetan Mesenchymal Stem Cell-derived Exosomes Alleviate Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension Rats.
    Stem Cells. 2024 May 8:sxae032. doi: 10.1093.
    PubMed    
    Abstract available

  49. CORDA A, Corda F, Pentcheva P, Puci M, et al
    The echocardiographic pulmonary to left atrial ratio: A noninvasive variable for the hemodynamic classification of pulmonary hypertension in dogs.
    J Vet Intern Med. 2024 May 7. doi: 10.1111/jvim.17097.
    PubMed    
    Abstract available

  50. MA JI, Owunna N, Jiang NM, Huo X, et al
    Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction.
    medRxiv [Preprint]. 2024 Apr 27:2024.04.25.24306398.
    PubMed    
    Abstract available

  51. LIU Q, Zhao C, Dang P, Li Y, et al
    Prognostic value of pulmonary hypertension with a nomogram in acute myocardial infarction patients with reduced left ventricular function.
    Front Cardiovasc Med. 2024;11:1368139.
    PubMed    
    Abstract available

  52. ZHANG J, Dong F, Ju G, Pan X, et al
    Sodium Houttuyfonate Alleviates MCT-induced Pulmonary Hypertension by Regulating Orai1 and Orai2.
    Am J Respir Cell Mol Biol. 2024 May 6. doi: 10.1165/rcmb.2023-0015.
    PubMed    
    Abstract available

  53. SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
    Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
    PeerJ. 2024;12:e17186.
    PubMed    
    Abstract available

  54. ALMUTAIRY BK, Khafagy ES, Aldawsari MF, Alshetaili A, et al
    Tailoring of Bilosomal Nanogel for Augmenting the Off-Label Use of Sildenafil Citrate in Pediatric Pulmonary Hypertension.
    ACS Omega. 2024;9:19536-19547.
    PubMed    
    Abstract available

  55. MERRILL K, Davis A, Jackson E, Riker M, et al
    Direct prostacyclin transition in pediatric patients with pulmonary hypertension.
    Pulm Circ. 2024;14:e12373.
    PubMed    
    Abstract available


  56. [Consensus on the procedure of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:404-418.
    PubMed    
    Abstract available

  57. ZHANG S, Gao L, Li S, Luo M, et al
    Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study.
    Cardiovasc Diabetol. 2024;23:154.
    PubMed    
    Abstract available

  58. TANG B, Vadgama A, Redmann B, Hong J, et al
    Charting the cellular landscape of pulmonary arterial hypertension through single-cell omics.
    Respir Res. 2024;25:192.
    PubMed    
    Abstract available

  59. MALIK AA, Saraswati U, Miranda WR, Covington M, et al
    Invasive Cardiac Hemodynamics in Apical Hypertrophic Cardiomyopathy.
    J Am Heart Assoc. 2024;13:e032520.
    PubMed    
    Abstract available

  60. ZHANG Z, Kutty S, Peng W, Zeng G, et al
    Causal association of depression, anxiety, cognitive performance, the brain cortical structure with pulmonary arterial hypertension: A Mendelian randomization study.
    J Affect Disord. 2024;356:356-362.
    PubMed    
    Abstract available

  61. YAMAMURA A, Fujiwara M, Kawade A, Amano T, et al
    Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Eur J Pharmacol. 2024;973:176564.
    PubMed    
    Abstract available

  62. HIRAKAWA K, Asano R, Ueda J, Aoki T, et al
    Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment.
    Int J Cardiol. 2024;406:132043.
    PubMed    
    Abstract available

  63. MANZI G, Recchioni T, Badagliacca R, Papa S, et al
    Fixed-dose combination therapy in pulmonary arterial hypertension: Pros & cons.
    Int J Cardiol. 2024;406:132003.
    PubMed    
    Abstract available

  64. KINGWELL K
    FDA approves Merck & Co's pulmonary arterial hypertension drug sotatercept.
    Nat Rev Drug Discov. 2024;23:327.
    PubMed    


  65. RATWATTE S, Stewart S, Strange G, Playford D, et al
    Association of Pulmonary Artery Pressures With Mortality in Adults With Reduced Left Ventricular Ejection Fraction.
    JACC Heart Fail. 2024;12:936-945.
    PubMed    
    Abstract available

  66. WANG Z, Zhang YX, Shi JZ, Yan Y, et al
    RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.
    Hypertens Res. 2024;47:1273-1287.
    PubMed    
    Abstract available

  67. KNIGHT DS, Virsinskaite R, Karia N, Cole AR, et al
    Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension.
    Rheumatology (Oxford). 2024 May 17:keae141. doi: 10.1093.
    PubMed    
    Abstract available

  68. HU T, Mu C, Li Y, Hao W, et al
    GPS2 ameliorates cigarette smoking-induced pulmonary vascular remodeling by modulating the ras-Raf-ERK axis.
    Respir Res. 2024;25:210.
    PubMed    
    Abstract available

  69. GRATE JC, Reynolds TS, Gordon AC, Dave SB, et al
    Infected Thrombosis Leading to Veno-Venous Extracorporeal Membrane Oxygenation Dysfunction in Chronic Thromboembolic Pulmonary Hypertension.
    ASAIO J. 2024 May 17. doi: 10.1097/MAT.0000000000002233.
    PubMed    
    Abstract available

  70. MASARONE D, Falco L, Catapano D, Gravino R, et al
    Dapagliflozin reverses combined postcapillary and precapillary pulmonary hypertension in a patient with advanced heart failure.
    Minerva Cardiol Angiol. 2024 May 16. doi: 10.23736/S2724-5683.24.06592.
    PubMed    


  71. ZHOU R, Lei Y, Ge L, Mao Q, et al
    Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.
    Ann Med. 2024;56:2352603.
    PubMed    
    Abstract available

  72. ADHYAPAK SM, Konda A, K T T, Shivakumar, et al
    Right heart catheterization in idiopathic pulmonary hypertension: An all-inclusive necessity.
    Curr Probl Cardiol. 2024;49:102642.
    PubMed    
    Abstract available

  73. CORVOL F, Hascoet S, Le Bret E, Nathan N, et al
    Scimitar syndrome with vein stenosis in an infant.
    BMJ Case Rep. 2024;17:e259955.
    PubMed    
    Abstract available

  74. SAINT-MARTIN WILLER A, El Jekmek K, Antigny F
    Therapeutic Potential of Sodium Houttuyfonate in Pulmonary Hypertension Through Orai-Ca2+ Channels.
    Am J Respir Cell Mol Biol. 2024 May 15. doi: 10.1165/rcmb.2024-0214.
    PubMed    


  75. ZEDER K, Brittain E, Kovacs G, Maron BA, et al
    The Management of Mild Pulmonary Hypertension in Clinical Practice.
    Ann Am Thorac Soc. 2024 May 15. doi: 10.1513/AnnalsATS.202312-1079.
    PubMed    
    Abstract available

  76. ZHANG X, Qin H, Ma Q, Zhang J, et al
    CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.
    Clin Respir J. 2024;18:e13771.
    PubMed    
    Abstract available

  77. BANERJEE S, Onwunyi VRC, Hong J, Martineau S, et al
    RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis via LOXL2 Mediated Mechanism.
    bioRxiv [Preprint]. 2024 May 3:2024.04.30.591766. doi: 10.1101/2024.04.30.591766
    PubMed    
    Abstract available

  78. YUAN Y, Li S, Yan M, Yang Y, et al
    Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study.
    BMC Pulm Med. 2024;24:235.
    PubMed    
    Abstract available

  79. GALIS R, Mudura D, Trif P, Diggikar S, et al
    Milrinone in persistent pulmonary hypertension of newborn: a scoping review.
    Pediatr Res. 2024 May 14. doi: 10.1038/s41390-024-03234.
    PubMed    
    Abstract available

  80. ELSEBAIE A, Enriquez VRB, Baranchuk A, Nahin MA, et al
    Atrial Arrhythmias Following Pulmonary Thromboendarterectomy: A Comprehensive Review Of Current Literature.
    Port J Card Thorac Vasc Surg. 2024;31:41-46.
    PubMed    
    Abstract available

  81. KANG K, Xiang J, Zhang X, Xie Y, et al
    N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
    Cell Mol Biol Lett. 2024;29:69.
    PubMed    
    Abstract available

  82. DESAI R, Katukuri N, Kanagala SG, Ghadge N, et al
    Examining prevalence and predictors of pulmonary hypertension in adults with idiopathic pulmonary fibrosis: a population-based analysis in the United States.
    J Med Life. 2024;17:35-40.
    PubMed    
    Abstract available

  83. RAWLINGS GH, Gaskell C, Beail N, Thompson A, et al
    Exploratory and confirmatory factor analysis of emPHasis-10: The health-related quality-of-life measure in pulmonary hypertension.
    Pulm Circ. 2024;14:e12378.
    PubMed    
    Abstract available

  84. VOHRA AS, Olonoff DA, Ip A, Kirtane AJ, et al
    Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012-2019).
    Pulm Circ. 2024;14:e12374.
    PubMed    
    Abstract available

  85. ATSUKAWA M, Koyano K, Iwakiri K
    [Portopulmonary hypertension (PoPH)].
    Nihon Shokakibyo Gakkai Zasshi. 2024;121:382-388.
    PubMed    


  86. BAE SP, Kim SS, Yun J, Lee H, et al
    Neonatal outcomes of preterm infants with pulmonary hypertension: clustering based on prenatal risk factors.
    Pediatr Res. 2024 May 11. doi: 10.1038/s41390-024-03232.
    PubMed    
    Abstract available

  87. NEMATI N, Burton T, Fathieh F, Gillins HR, et al
    Pulmonary Hypertension Detection Non-Invasively at Point-of-Care Using a Machine-Learned Algorithm.
    Diagnostics (Basel). 2024;14:897.
    PubMed    
    Abstract available

  88. RIOU M, Coste F, Meyer A, Enache I, et al
    Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.
    Int J Mol Sci. 2024;25:4941.
    PubMed    
    Abstract available

  89. CHATZIDAVID S, Flevari P, Tombrou I, Anastasiadis G, et al
    Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.
    Int J Mol Sci. 2024;25:4792.
    PubMed    
    Abstract available

  90. BAHI M, Li C, Wang G, Korman BD, et al
    Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.
    Int J Mol Sci. 2024;25:4728.
    PubMed    
    Abstract available

  91. YAMANO M, Yamano T, Matoba S
    Right ventricular dilatation: echocardiographic differential diagnosis.
    J Med Ultrason (2001). 2024;51:275-282.
    PubMed    
    Abstract available

  92. KRAMER T, Nattmann P, Gerhardt F, Stafiej P, et al
    Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension.
    ESC Heart Fail. 2024;11:1540-1552.
    PubMed    
    Abstract available

  93. FAVOINO E, Prete M, Liakouli V, Leone P, et al
    Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity.
    Autoimmun Rev. 2024;23:103514.
    PubMed    
    Abstract available

  94. THOREAU B, Mouthon L
    Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
    Autoimmun Rev. 2024;23:103506.
    PubMed    
    Abstract available

  95. OH Y, Park K, Jung S, Choi M, et al
    Inhalable Nitric Oxide Delivery Systems for Pulmonary Arterial Hypertension Treatment.
    Small. 2024;20:e2308936.
    PubMed    
    Abstract available

  96. NIEDERMEYER S, Yun X, Trujillo M, Jiang H, et al
    A novel interaction between aquaporin 1 and caspase-3 in pulmonary arterial smooth muscle cells.
    Am J Physiol Lung Cell Mol Physiol. 2024;326:L638-L645.
    PubMed    
    Abstract available

  97. VILLAMOR E, Gonzalez-Luis GE
    Pulmonary Hypertension and Lung Damage Associated with Prolonged Exposure to Patent Ductus Arteriosus in Very Preterm Infants.
    Am J Respir Crit Care Med. 2024 May 3. doi: 10.1164/rccm.202404-0694.
    PubMed    


  98. KAWUT SM, Feng R, Ellenberg SS, Zamanian R, et al
    Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Am J Respir Crit Care Med. 2024 May 15. doi: 10.1164/rccm.202402-0371.
    PubMed    
    Abstract available

  99. OLDROYD SH, Manek G, Bhardwaj A, Zamanian RT, et al
    Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2024;209:1189-1195.
    PubMed    
    Abstract available

  100. GENECAND L, Lador F, Montani D, Perneger T, et al
    Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?
    Chest. 2024;165:e161.
    PubMed    


  101. CHEN Y, Li J, Li F, Chen Z, et al
    Impact of Epicardial Adipose Tissue on Right Cardiac Function and Prognosis in Pulmonary Arterial Hypertension.
    Chest. 2024;165:1211-1223.
    PubMed    
    Abstract available

  102. RICE JL, Austin ED, Mathai SC, Sahay S, et al
    Genetic Testing in Pulmonary Arterial Hypertension Evaluation: A Patient and Clinician Survey.
    Chest. 2024;165:1224-1227.
    PubMed    


  103. ZAFEIROPOULOS S, Ahmed U, Bekiaridou A, Jayaprakash N, et al
    Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension.
    Circ Res. 2024 May 7. doi: 10.1161/CIRCRESAHA.123.323679.
    PubMed    
    Abstract available

  104. ZHANG J, Li Y, Chen Y, Zhang J, et al
    o(8)G Site-Specifically Modified tRF-1-AspGTC: A Novel Therapeutic Target and Biomarker for Pulmonary Hypertension.
    Circ Res. 2024 May 15. doi: 10.1161/CIRCRESAHA.124.324421.
    PubMed    
    Abstract available

  105. RUBIN LJ
    Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?
    Circulation. 2024;149:1565-1567.
    PubMed    


  106. GERHARDT F, Fiessler E, Olsson KM, Kayser MZ, et al
    Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Circulation. 2024 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.063821.
    PubMed    
    Abstract available

  107. FLOREZ ID, Parra-Rodas L
    Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment?
    Crit Care Med. 2024;52:995-997.
    PubMed    


  108. GRYNBLAT J, Khouri C, Hlavaty A, Jais X, et al
    Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
    Eur Respir J. 2024 May 2:2302158. doi: 10.1183/13993003.02158-2023.
    PubMed    
    Abstract available

  109. MA JL, Wang AY, Lu D, Cheng CY, et al
    The puzzles surrounding the impact of face masks on 6-minute walking distance in pulmonary hypertension.
    Eur Respir J. 2024;63:2301879.
    PubMed    


  110. WISSMULLER M, Wartner V, Hohmann C, Adler J, et al
    Reply to: The puzzles surrounding the impact of face masks on 6-minute walking distance in pulmonary hypertension.
    Eur Respir J. 2024;63:2400529.
    PubMed    


  111. KANEZAWA M, Shimokawahara H, Ejiri K, Goten C, et al
    Effects of medical therapy and age on cardiac output changes following balloon pulmonary angioplasty: Implications for combination therapy in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2024 May 15:S1053-2498(24)01661.
    PubMed    
    Abstract available

  112. AGAOGLU ES, Semple T, Wells AU, Wort S, et al
    Unilateral pleural effusion with pulmonary hypertension in sarcoidosis: do not forget the pulmonary veins!
    Thorax. 2024 Apr 29:thorax-2023-220058. doi: 10.1136/thorax-2023-220058.
    PubMed    



Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;